Free Trial

NIOX Group (LON:NIOX) Trading 1.5% Higher - Still a Buy?

NIOX Group logo with Medical background

NIOX Group Plc (LON:NIOX - Get Free Report)'s stock price traded up 1.5% on Friday . The company traded as high as GBX 70 ($0.94) and last traded at GBX 69.40 ($0.93). 649,157 shares traded hands during mid-day trading, a decline of 43% from the average session volume of 1,138,227 shares. The stock had previously closed at GBX 68.40 ($0.92).

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Berenberg Bank reiterated a "buy" rating and issued a GBX 90 ($1.21) price target on shares of NIOX Group in a research report on Tuesday, April 15th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 90 ($1.21) price target on shares of NIOX Group in a research report on Tuesday, April 15th.

View Our Latest Research Report on NIOX

NIOX Group Stock Up 0.6%

The company has a market cap of £28.26 billion, a price-to-earnings ratio of 2,839.26 and a beta of 0.92. The stock has a fifty day moving average price of GBX 67.16 and a two-hundred day moving average price of GBX 64.87. The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10.

Insider Buying and Selling

In other news, insider Jonathan Emms sold 2,745,925 shares of the firm's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total transaction of £1,784,851.25 ($2,396,416.82). Also, insider Ian Johnson sold 3,924,630 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total value of £2,551,009.50 ($3,425,093.31). 46.72% of the stock is owned by corporate insiders.

About NIOX Group

(Get Free Report)

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

Further Reading

Should You Invest $1,000 in NIOX Group Right Now?

Before you consider NIOX Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NIOX Group wasn't on the list.

While NIOX Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines